Artificial Intelligence And Robotic Technology: New Future For Cancer Services

By Goldstein Market Intelligence || 2018-02-03 2:35:31 AM

Artificial Intelligence And Robotic Technology: New Future For Cancer Services

According to Goldstein Research, “Growing awareness about preventive measures for cancer is driving the demand for cancer services. People are more welcoming towards preventive measure rather than opting for high cost surgeries and treatments for cancer. Adoption of vaccination against human papilloma virus (HPV) and hepatitis B viruses is expected to prevent over 1 million cancer cases every year. Adoption of oral medicines over injections are making cancer therapies much easier and acceptable resulting in the expansion of cancer services market across the globe.”

“Global Cancer Services Market Outlook 2024”

The global cancer services market is segmented on the basis of preventive care services, by diagnostic care services, by application and by end-user. Preventive care services are further bifurcated into vaccines and cancer growth inhibitors. Vaccines are the dominating segment of cancer services market owing to its positive results in cancer treatment. Vaccines for cancer services market valued USD 54.86 billion in 2015 and are expected to occupy over 62% market share over the forecast period.

Cancer diagnostic care services market is growing rapidly in Asia-Pacific region due to increasing frequency of breast, stomach and lungs cancer. Asia-Pacific cancer services market is expected to reach USD 61.3 billion in 2024, registering a healthy CAGR over the forecast period. However, lack of amenities and awareness among the low income group countries region is likely to impact negatively for the growth of cancer services market in Asia-Pacific region.

Expiration of Patent drugs: Insurgence in medical industry

Rise in ageing population majorly in developing economies raising serious demand for cancer services. Advanced treatment facilities and reimbursement policies by government are encouraging the adoption of cancer services across the globe. However, patent expiration of major cancer treatment drugs has created a new challenge for research & development industries. Developed economies are more investing in R&D to develop new innovative drugs for cancer treatment. Researchers are also focusing into the implementation of big data in early phase of clinical trials to provide effective treatment for the patients.

 “Global Cancer Services Market Outlook 2024” contains detailed overview of the global cancer services market in terms of market segmentation by preventive care services, by diagnostic care services, by application and by end-user.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Porter’s five force model and SWOT analysis.

Global cancer services market also provides competitive outlook of some of the major players of global cancer services market which includes profiling of companies such as GE Healthcare, Philips Healthcare, Siemens Healthcare, Novartis, Abbott Diagnostics, Roche, Pfizer Inc., Sanofi, Amgen, Merck & Co., GlaxoSmithKline, Johnson & Johnson, Amgen Inc., Eli Lilly and Company, Hoffman La-Roche Ltd. and Roche Holdings Ltd. The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services and industries catered, financial analysis of the company and recent developments.

Overall, the report represents comprehensive synopsis on the global cancer services market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

Send Us Sample Request

Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.

Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear cut forecasts. Backed up by reliable research and impactful statistics, our business solutions empower our clients to grow at a fast pace despite unsettling fluctuations in the market. We believe in vigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable to our clients’ needs and business agenda.